PULSE: Make Up Your Mind: Direct Oral Anticoagulant Reversal in Intracranial Hemorrhage
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Target Audience
Pharmacist
Learning Objectives
- Identify patients indicated for anticoagulation reversal with intracranial hemorrhage (ICH).
- Describe the utilization and limitations of reversal agents for direct oral anticoagulants (DOACs).
- Discuss literature regarding the efficacy and safety of both Andexanet alfa (Andexxa®) and 4-Factor Prothrombin Complex Concentrate (Kcentra®).
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Marissa L. Campagna, PharmD
PGY2 Critical Care Pharmacy Resident
UPMC Presbyterian
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.